Clinical Trial Update: S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed [Phase 2]

View source ↗

Summary

A Phase 2 trial (S0030) evaluating capecitabine in older patients with metastatic or recurrent colorectal cancer that cannot be surgically removed has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED